hotspot -WSS

hotspot

author：fashion 2025-09-30 06:09:24 - browse：94266

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Cancer drug shortages should be causing more outrage

WSS

Beyond aggravation: Constipation is an American epidemic

Peter Hotez and the public health issue of online harassment

Medicare proposal to cover medical devices draws a mixed reaction

Hepatitis C has a cure — but many Americans still lack access to it

Achieving telehealth equity for people with hearing loss

23andMe had bad news about my health. I wish a person had delivered it

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Heart attack and stroke risk calculators need revising

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why some fertility treatments produce more boy babies

Drug repurposing or repositioning? The language matters

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Alkermes shareholders re

Tori Bowie and the unacceptable rates of Black maternal death

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why some fertility treatments produce more boy babies

explore

Some medical students still think black patients feel less pain

The world needs the new pandemic treaty

Malaria cases in Florida and Texas: Here’s what you need to know

Psychedelics group wrestles with new pharma identity

New research sheds light on how often breast cancer is overdiagnosed

In Memoriam: Notable people who died in 2023

hotspot

entertainment

explore

knowledge